¹é½Å ¼öŹÁ¦Á¶ ½ÃÀå - Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ¹é½Å À¯Çüº°, ¿ëµµº°, ÇÁ·Î¼¼½ºº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)
Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type ; By Application; By Process; By Region; Segment Forecast, 2023- 2032
»óǰÄÚµå : 1421745
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 119 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,149,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 131¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô ÀλçÀÌÆ®ÇÏ°í ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

Á¦¾à ¹× ¹ÙÀÌ¿À ÀǾàǰ ±â¾÷Àº Àü·«ÀûÀ¸·Î ÇÙ½É ¿ª·®À» ¿ì¼±½ÃÇÏ°í °¡°Ý °æÀïÀÇ °ÝÈ­¸¦ ±Øº¹ÇÏ·Á°í Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ¼öŹÁ¦Á¶¿¡ ´ëÇÑ °æ»ç°¡ °­ÇØÁö°í ÀÖ½À´Ï´Ù.

±×·¯³ª ¹é½ÅÀÇ Á¦Á¶´Â ¾ÈÀü¼º, È¿´É ¹× Àϰü¼ºÀ» º¸ÀåÇϱâ À§ÇØ ³ë·ÂÇÏ´Â Á¦Á¶¾÷ü¿¡°Ô º¹ÀâÇÑ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀåÀº Á¦Á¶ °øÁ¤, Á¦Á¶ ½Ã¼³ÀÇ ¼³¸³°ú ¿î¿µ, ¼¼Æ÷ÁÖ °³Ã´, ¹ßÈ¿, °øÁ¤ °³·®, ºÐ¼® Ư¼º Æò°¡ µîÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¼­ºñ½º¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â Àü¹ÝÀûÀ¸·Î ¼¼°è ¼öÁØ¿¡¼­ ½ÃÀåÀÇ »ó´çÇÑ ¼ºÀåÀ» À̲ø¾î³»´Â ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¿¹¹æ Á¢Á¾Àº Àΰ£°ú °¡ÃàÀÇ °Ç°­ ÁõÁø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Ç×»ýÁ¦¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÏ »Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ °­·ÂÇÑ ¾ïÁ¦·Â ¿ªÇÒµµ ÇÕ´Ï´Ù. ½É°¢ÇÑ Áúº´À̳ª °¨¿°À¸·ÎºÎÅÍ ¸öÀ» ÁöŰ´Â µî, ¿¹¹æÁ¢Á¾¿¡´Â ¿©·¯°¡Áö ÀÌÁ¡ÀÌ ÀÖ´Ù´Â °ÍÀÌ ÀνĵǾî, ¿¹¹æÁ¢Á¾ÀÇ ´ëó³ª Á¢Á¾ ÇÁ·Î±×·¥ÀÌ ³Î¸® È£¼ÒµÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó Á¦Á¶¿¡´Â »ó´çÇÑ ÀÚº»ÀÌ ÇÊ¿äÇÏ´Ù´Â ÀνĿ¡¼­ ´ëÇü Á¦¾à ±â¾÷Àº ¹é½Å Á¦Á¶ ºÐ¾ß¿¡¼­ ¾Æ¿ô¼Ò½ÌÀ» ¼±ÅÃÇÏ°Ô µÇ¾ú½À´Ï´Ù.

±×·¯³ª, ÀÚ¿øÀÌ ºÎÁ·ÇÑ ³ª¶ó¿¡¼­´Â ¹é½Å Á¦Á¶¸¦ À§ÇÑ ¼³ºñ³ª ¼÷·ÃµÈ ³ëµ¿·ÂÀÌ ºÎÁ·Çϰí, À̰ÍÀÌ ¼¼°èÀÇ ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇÏ´Â Å« ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ EB66°ú GPEx¿Í °°Àº ÷´Ü ¹ßÇö ½Ã½ºÅÛÀÇ µµÀÔ°ú Çõ½ÅÀûÀÎ ¼¼Æ÷ ¹è¾ç ¹èÁö Ç÷§ÆûÀº ½ÃÀå ¼ºÀåÀÇ Å« Áö¿øÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ ±¹°¡¿¡¼­ COVID-19ÀÇ Áõ·Ê°¡ ±ÞÁõÇϰí Àֱ⠶§¹®¿¡ ¹é½Å°³¹ß±â¾÷Àº Á¦Á¶¼öʱâ°ü(CMO)°úÀÇ ¾Æ¿ô¼Ò½Ì °è¾à¿¡ ÀÓÇÏ°í ½ÃÀ尳ôÀ» À§ÇÑ ±àÁ¤ÀûÀÎ ±Ëµµ°¡ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù.

¹é½Å ¼öŹÁ¦Á¶ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ºÒȰȭ ¹é½Å ºÐ¾ß´Â È¿À²¼ºÀÌ ³ô±â ¶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGRÀÌ ¿¹»óµË´Ï´Ù.

2022³â¿¡´Â µ¿¹°¿ë ¹é½Å Á¦Á¶¿¡ À־ CMOÀÇ ÀÌ¿ë È®´ë°¡ ÁÖÀÎÀÌ µÇ¾î, µ¿¹°¿ë ºÎ¹®ÀÌ ¼öÀÍ Á¡À¯À²¿¡¼­ Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2022³â, ´Ù¿î½ºÆ®¸² ºÐ¾ß´Â ±â¼úÀÇ Áøº¸¿Í Çõ½ÅÀ¸·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2022³â¿¡´Â ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â ±â¼úÀÇ ºñ¾àÀûÀÎ ¼ºÀå°ú ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀ庰 ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀå : ¹é½Å À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀå : ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀå : ÇÁ·Î¼¼½ºº°

Á¦8Àå ¼¼°èÀÇ ¹é½Å ¼öŹÁ¦Á¶ ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global vaccine contract manufacturing market size is expected to reach USD 13.16 billion by 2032, according to a new study by Polaris Market Research. The report "Vaccine Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type (Inactivated Vaccine, DNA Vaccines, Attenuated Vaccine, Toxoid Vaccines, Subunit Vaccines); By Application; By Process; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical and biopharmaceutical companies are strategically prioritizing their core competencies to navigate the escalating price pressures. Consequently, there is a growing inclination towards contract manufacturing.

However, vaccine production presents a complex challenge for manufacturers as they strive to guarantee safety, effectiveness, and consistency. The vaccine contract manufacturing market is driven by a diverse range of services encompassing production processes, the establishment and operation of manufacturing facilities, cell line development, fermentation, process refinement, and analytical characterization. These services collectively play a pivotal role in driving the market's substantial growth on a worldwide level.

Vaccination plays an important role in enhancing both human and veterinary health. It not only diminishes reliance on antibiotics but also serves as a potent deterrent against various diseases. The escalating recognition of its manifold advantages, which include safeguarding against severe illnesses and infectious conditions, is fueling the call for widespread immunization initiatives and inoculation programs. In tandem with this, the cognizance of the substantial capital outlay needed for production has prompted major pharmaceutical entities to opt for outsourcing in the realm of vaccine manufacturing.

However, in low-resource countries, the shortage of equipment and proficient labor for vaccine production is a significant factor driving the expansion of the global vaccine contract manufacturing market. Additionally, the introduction of advanced expression systems such as EB66 and GPEx, along with innovative cell culture media platforms, is providing substantial support for market growth. Furthermore, the surging instances of COVID-19 in various nations have prompted vaccine developers to engage in outsourcing agreements with Contract Manufacturing Organizations (CMOs), fostering a positive trajectory for market advancement.

Vaccine Contract Manufacturing Market Report Highlights

The Inactivated Vaccine segment is expected to witness the fastest CAGR during the forecast period on account of better efficiency.

The veterinary segment held a significant share in revenue share in 2022, which is mainly driven by increased utilization of CMOs in the production of animal vaccinations.

In 2022, the downstream segment held the largest market share due to technological advancements and innovation.

In 2022, the North American region held the largest market share, owing to exponential growth in technology and rising R&D investments.

The global key market players include: Fujifilm Diosynth Biotechnologies, IDT Biologika GmbH, KBI Biopharma, Lonza Group, Merck KGaA, and more.

Polaris Market Research has segmented the vaccine contract manufacturing market report based on vaccine type, application, process, and region:

Vaccine Contract Manufacturing, Vaccine Type Outlook (Revenue - USD Billion, 2019 - 2032)

Vaccine Contract Manufacturing, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Vaccine Contract Manufacturing, Process Outlook (Revenue - USD Billion, 2019 - 2032)

Vaccine Contract Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Vaccine Contract Manufacturing Market Insights

5. Global Vaccine Contract Manufacturing Market, by Vaccine Type

6. Global Vaccine Contract Manufacturing Market, by Application

7. Global Vaccine Contract Manufacturing Market, by Process

8. Global Vaccine Contract Manufacturing Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â